Pulse Biosciences director granted new stock options
PULSE BIOSCIENCES, INC. director Mahkam Zanganeh reported receiving two stock option grants.
Rhea-AI Filing Summary
PULSE BIOSCIENCES, INC. director Mahkam Zanganeh reported receiving two stock option grants. The options cover 14,504 and 30,000 shares of common stock at an exercise price of $26.89 per share and expire on June 11, 2036.
The 14,504-share option vests in equal monthly installments over one year starting on July 11, 2026, subject to continued service. The 30,000-share option vests in equal quarterly installments over one year starting on September 5, 2026. These are compensation-related awards, not open-market share purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 44,504 shares
Grant/Award
2 txns
Insider
Zanganeh Mahkam
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 30,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 14,504 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 44,504 contracts (Direct)
Footnotes (2)
- F1. The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026.
- F2. The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026.
Key Figures
Option grant size 1: 14,504 options
Option grant size 2: 30,000 options
Exercise price: $26.89 per share
+3 more
6 metrics
Option grant size 1
14,504 options
Stock option grant to director Mahkam Zanganeh
Option grant size 2
30,000 options
Second stock option grant to Mahkam Zanganeh
Exercise price
$26.89 per share
Exercise price for both option grants
Expiration date
June 11, 2036
Expiration for both stock option grants
Monthly vesting start
July 11, 2026
First vesting date for 14,504-share grant
Quarterly vesting start
September 5, 2026
First vesting date for 30,000-share grant
Key Terms
Stock Option (right to buy), exercise price, vesting, equal monthly installments, +2 more
6 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 26.8900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to the option will vest in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
equal monthly installments financial
"will vest in equal monthly installments over a one-year period"
equal quarterly installments financial
"will vest in equal quarterly installments over a one-year period"
expiration date financial
"expiration_date: 2036-06-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PULSE BIOSCIENCES (PLSE) director Mahkam Zanganeh report on this Form 4?
Mahkam Zanganeh reported receiving two stock option grants as compensation. The awards cover 14,504 and 30,000 shares of common stock, giving the right to buy shares at a fixed exercise price of $26.89 per share until June 11, 2036.
How many stock options were granted to Mahkam Zanganeh at PULSE BIOSCIENCES (PLSE)?
Two separate option grants were reported for Mahkam Zanganeh. One covers 14,504 shares and the other covers 30,000 shares of PULSE BIOSCIENCES common stock, both structured as stock options with a fixed exercise price and defined vesting schedules over one-year periods.
What is the exercise price and expiration date of the PLSE options granted to Mahkam Zanganeh?
Both option grants have an exercise price of $26.89 per share and share the same expiration date. The options expire on June 11, 2036, giving Zanganeh the right to purchase the underlying common shares any time after vesting and before expiration.
Does this PLSE Form 4 show Mahkam Zanganeh buying or selling common stock on the market?
No, the filing reports compensation-related stock option grants, not market trades. The transactions are coded as awards, giving Zanganeh future rights to purchase shares at $26.89 per share, rather than immediate open-market purchases or sales of common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
